Next-gen Immunoregulatory Bioelectronic Patch For Skin Inflammation
SUMMARY
An electronic system that incorporates living materials as an interfacial layer, specially tailored for managing skin inflammation diseases.
The Unmet Need: Chronic skin diseases lack safe, drug-free, continuous monitoring and immunomodulatory solutions- current options are costly, invasive, or limited in efficacy
- Millions suffer from chronic inflammatory skin diseases (psoriasis, eczema, wounds) with restricted access to continuous, noninvasive monitoring or drug-free treatment. Conventional bioelectronics and wearables monitor skin signals but fall short in integrating biological modulation, mechanical conformity, and robust data analytics. Hospitals and telehealth providers increasingly demand solutions that are wireless, adhesive, biohazard-controlled, and able to directly intervene in tissue inflammation. Recent advances in hydrogels, flexible electronics, and living microbe/immune integration have made bioactive interfaces possible but have yet to break into mainstream care.
The Proposed Solution: ABLE is a living bioelectronic skin patch enabling wireless, drug-free monitoring and immunomodulation for inflammatory skin diseases, designed for seamless hospital or home integration
- The faculty inventor developed the Active Biointegrated Living Electronics (ABLE) platform- a next-generation bioelectronic system combining a skin-adhesive hydrogel and live Staphylococcus epidermidis–laden composites with flexible electronic arrays for skin monitoring and therapy. The system enables high-fidelity physiological recordings, real-time recovery tracking, and immunoregulation for psoriasis and beyond. It further allows wireless control and safe biohazard disposal- addressing key bottlenecks for regulatory, hospital, and consumer adoption. ABLE’s platform approach supports rapid customization for different disease states, endpoints, and integration with hospital networks or home monitoring apps. Market pressures for payer and regulatory approval are accelerating; early hospital pilot results show robust demand for such integrated therapeutic/diagnostic devices.
ADVANTAGES
-
Integrated electrical and biogenic signal detection/adaptation
-
Drug-free, targeted immunomodulation
-
Wireless, real-time hospital data transfer and analytics
-
Long-term skin adhesion, minimal invasiveness
-
On-demand in situ disinfection for safe clinical use
APPLICATIONS
-
Psoriasis and atopic dermatitis therapy and monitoring
-
Advanced wound healing protocols in hospitals/clinics
-
Remote patient management for telehealth providers
-
Clinical trial adjuncts, device-drug combinations